# A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

> **NCT00386347** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (—)

## Conditions studied

- HIV Infection
- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** GSK364735 oral solution and oral tablets

## Key facts

- **NCT ID:** NCT00386347
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 56 (—)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386347, "A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00386347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*